Mar 17, 2023, 12:15:00 AM

PromarkerD Application for Australian Medicare Benefits Schedule Listing & Investor Webinar

Proteomics International Laboratories Ltd is pleased to provide a copy of the Q&A session with investors regarding the recent announcement on company’s application for PromarkerD’s listing on the Australian Medicare Benefits Schedule.

ASX Release

Application for Australian Medicare Benefits Schedule Listing for PromarkerD Webinar

26:43

2023

Funds from the Placement will be used for:

Proteomics International is proud to announce it has secured CE Mark registration for PromarkerD...

“Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, has...

PromarkerD Application for Australian Medicare Benefits Schedule Listing & Investor Webinar

Related posts

Proteomics International raises $6m in heavily oversubscribed Placement

CE Mark for predictive test for diabetic kidney disease

Finfeed – Proteomics awarded vital CE Mark registration for PromarkerD